Newsletters

Global Life Science Business Partnering (GLSBP) - September 2024

Highlights of Deals in September 20241.      Aurobindo to acquire 49 percent stake in GLS Pharma. 2.   &n...

Read More

Global Life Science Business Partnering (GLSBP) - August 2024

Highlights of Deals in August 2024 1.     Dr Reddy's invests INR 734 crore(US$87.42 Million) in JV with Nestle India (Nutriti...

Read More

Global Life Science Business Partnering (GLSBP) - July 2024

Highlights of Deals in July 20241.     Mankind to acquire Bharat Serums and Vaccines (BSV) from Advent International for INR 13,60...

Read More

Global Life Science Business Partnering (GLSBP) - June 2024

Greetings. Hope you had a wonderful July 4 extended Holiday period.Highlights of Deals in June 20241.     A consortium of Warburg ...

Read More

Global Life Science Business Partnering (GLSBP) - May 2024

Highlights of May 20241.      Cipla to invest Rs 26 crore (US$~3.1 million) more in Achira Labs.2.    &...

Read More

Global Life Science Business Partnering (GLSBP) - April 2024

Highlights of April 2024 1.     Cipla to acquire Ivia Beaute's cosmetics, personal care distribution and marketing busin...

Read More

Global Life Science Business Partnering (GLSBP) - March 2024

Highlights of March 2024 1.     Mankind Pharma enters exclusive pact to distribute AstraZeneca's anti-asthma drug Symbicort i...

Read More

Global Life Science Business Partnering (GLSBP) - February 2024

Highlights of February 2024:Eris acquires 51% stake in Swiss Parenterals for INR 637.5 Crore (US$79.7 Million).Sun Pharma to acquire 16.33% stake in S...

Read More

Global Life Science Business Partnering (GLSBP) - January 2024

Highlights of January 2024:Sun Pharmaceutical Industries to buy remaining stake in Taro Pharmaceutical Industries for $347.8 million.US fund Platinum ...

Read More

Global Life Science Business Partnering (GLSBP) - December 2023

Highlights of December 20231.      JB Chem to acquire select ophthalmology brands of Novartis India for INR 1,089 crores (~...

Read More

×
Twitter